These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31310746)

  • 1. Development of Autoimmune Interstitial Lung Disease in a Patient with Inclusion Body Myositis.
    He C; Lee JS; Cool CD; Wicklund MP; Fischer A
    Am J Med; 2019 Dec; 132(12):e854-e855. PubMed ID: 31310746
    [No Abstract]   [Full Text] [Related]  

  • 2. Interstitial lung disease in antisynthetase syndrome without clinical myositis.
    Sundaragiri PR; Vallabhajosyula S; Kanaan JP
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24700049
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe inclusion body myositis with interstitial pneumonia.
    Mori S; Hamada H; Yokoyama A; Kohno N; Kondo K; Hara Y; Kawata H; Hiwada K
    Intern Med; 2001 Sep; 40(9):940-4. PubMed ID: 11579961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
    Chartrand S; Swigris JJ; Stanchev L; Lee JS; Brown KK; Fischer A
    Respir Med; 2016 Oct; 119():150-154. PubMed ID: 27692137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of inclusion body myositis with subacute cutaneous lupus erythematosus.
    Wenzel J; Uerlich M; Gerdsen R; Bieber T; Boehm I
    Rheumatol Int; 2001 Oct; 21(2):75-7. PubMed ID: 11732863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 48-year-old woman with prior liver disease presenting with dyspnea and ground glass opacities.
    Hamburg BJ; Schneider F; Woodske ME
    Chest; 2012 May; 141(5):1351-1355. PubMed ID: 22553270
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary Capillaritis in a Patient With Antisynthetase Syndrome and Anti-PL-7 Antibodies.
    Richardson C; Haque UJ
    J Clin Rheumatol; 2019 Sep; 25(6):e91-e92. PubMed ID: 29742539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
    Mecoli CA; Christopher-Stine L
    Curr Rheumatol Rep; 2018 Apr; 20(5):27. PubMed ID: 29637383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion body myositis in connective tissue disorders: case report and review of the literature.
    Derk CT; Vivino FB; Kenyon L; Mandel S
    Clin Rheumatol; 2003 Oct; 22(4-5):324-8. PubMed ID: 14576992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IgG4-related systemic disease].
    Clavero Fernández E; Souto Ruzo J; Alonso Aguirre P; Yáñez López JÁ; Fernández Armendáriz P
    Gastroenterol Hepatol; 2015 Nov; 38(9):547-8. PubMed ID: 25306960
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis.
    Koffman BM; Rugiero M; Dalakas MC
    Muscle Nerve; 1998 Jan; 21(1):115-7. PubMed ID: 9427231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of antigen-driven mechanisms in interstitial pneumonia with polymyositis.
    Fukushima Y; Takeda A; Matsutani T; Fukushima F; Furihata T; Maezawa R; Miyoshi M; Hirata H; Sugiyama K; Okada M; Fukuda T
    Rheumatology (Oxford); 2013 Aug; 52(8):1537-40. PubMed ID: 23413025
    [No Abstract]   [Full Text] [Related]  

  • 13. POINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? Yes.
    Lee JS; Fischer A
    Chest; 2019 Feb; 155(2):258-260. PubMed ID: 30732687
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term observational study of sporadic inclusion body myositis.
    Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
    Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary alveolar proteinosis: a new autoimmune disease.
    Costabel U; Guzman J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S67-73. PubMed ID: 16457018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Cogan's syndrome resolved with mycophenolate sodium.
    Di Leo E; Dambra PP; Capuzzimati L; Giovine A; Guerriero S; Nettis E; Vacca A
    Eur J Clin Invest; 2008 Aug; 38(8):605. PubMed ID: 18717829
    [No Abstract]   [Full Text] [Related]  

  • 19. The lung as a possible target for the immune reaction in myositis.
    Danoff SK; Casciola-Rosen L
    Arthritis Res Ther; 2011 Jul; 13(4):230. PubMed ID: 21787440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
    Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
    Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.